Proteocyte Diagnostics: New Study Provides More Straticyte™ Support

Ontario Industry Updates
Written By Guest User

A newly published study provides further data showing Straticyte offers better predictive insight over histopathological dysplasia grading for oral potentially malignant lesion assessment.

The study “Straticyte demonstrates prognostic value over oral epithelial dysplasia grade for oral potentially malignant lesion assessment” was just published online in Oral Oncology and can be accessed here.

For the full press release, click here.

Guest User
Previous

Rna Diagnostics Inc. appoints Dr. Matthew P. Goetz to Clinical Advisory Board
Next

CAAP Company: KA Imaging receives funding from FACIT